ATE543906T1 - Antigen von streptococcus aus der b-gruppe - Google Patents

Antigen von streptococcus aus der b-gruppe

Info

Publication number
ATE543906T1
ATE543906T1 AT03701402T AT03701402T ATE543906T1 AT E543906 T1 ATE543906 T1 AT E543906T1 AT 03701402 T AT03701402 T AT 03701402T AT 03701402 T AT03701402 T AT 03701402T AT E543906 T1 ATE543906 T1 AT E543906T1
Authority
AT
Austria
Prior art keywords
streptococcus
group
antigen
epitopes
gbs
Prior art date
Application number
AT03701402T
Other languages
English (en)
Inventor
Stephane Rioux
Denis Martin
Josee Hamel
Bernard Brodeur
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of ATE543906T1 publication Critical patent/ATE543906T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03701402T 2002-02-11 2003-02-11 Antigen von streptococcus aus der b-gruppe ATE543906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35494702P 2002-02-11 2002-02-11
PCT/CA2003/000186 WO2003068813A2 (en) 2002-02-11 2003-02-11 Group b streptococcus antigen

Publications (1)

Publication Number Publication Date
ATE543906T1 true ATE543906T1 (de) 2012-02-15

Family

ID=27734441

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03701402T ATE543906T1 (de) 2002-02-11 2003-02-11 Antigen von streptococcus aus der b-gruppe

Country Status (8)

Country Link
US (1) US20070275004A1 (de)
EP (1) EP1472353B1 (de)
JP (1) JP2005535287A (de)
AT (1) ATE543906T1 (de)
AU (1) AU2003203097C1 (de)
CA (1) CA2475821C (de)
ES (1) ES2381967T3 (de)
WO (1) WO2003068813A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2321106C (en) 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
CA2881568C (en) 2000-10-27 2019-09-24 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from streptococcus groups a & b
ES2505695T3 (es) 2003-07-31 2014-10-10 Novartis Vaccines And Diagnostics, Inc. Composiciones inmunógenas para Streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
JP2008508320A (ja) 2004-07-29 2008-03-21 カイロン コーポレイション Ｓｔｒｅｐｔｏｃｏｃｃｕｓａｇａｌａｃｔｉａｅのようなグラム陽性細菌に対する免疫原性組成物
EP1845944A4 (de) * 2005-02-08 2011-07-27 Id Biomedical Corp Of Quebec C O B As Glaxosmithkline Biolog North America Pharmazeutische zusammensetzungen
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
KR101621837B1 (ko) 2007-09-12 2016-05-17 노파르티스 아게 Ｇａｓ57 돌연변이 항원 및 ｇａｓ57 항체
CN103834669B (zh) * 2014-02-21 2016-06-29 通威股份有限公司 一种无乳链球菌的口服疫苗及其制备方法
CN107502622A (zh) * 2016-06-14 2017-12-22 广东省农业科学院动物卫生研究所 Sip基因重组载体、壳聚糖‑PLGA包裹Sip基因DNA疫苗及其制备方法和应用
AU2019286648B2 (en) 2018-06-13 2023-11-23 Gen-Probe Incorporated Compositions and methods for detecting group B Streptococcus nucleic acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) * 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5679768A (en) * 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
HU217582B (hu) * 1993-03-19 2000-02-28 Gunnar Lindahl Streptococcus B csoportba tartozó törzsek elleni immunitást biztosító, Rib fehérjenevű felületi protein, eljárás a protein tisztítására, reagenskészlet és gyógyszerkészítmény
US5595740A (en) * 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
TW448184B (en) * 1994-11-01 2001-08-01 Kirin Brewery Peptide sequence that forms muscous glycoprotein chain and technique for producing thereof
CA2321106C (en) * 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins

Also Published As

Publication number Publication date
US20070275004A1 (en) 2007-11-29
ES2381967T3 (es) 2012-06-04
EP1472353B1 (de) 2012-02-01
WO2003068813A3 (en) 2003-10-16
WO2003068813A2 (en) 2003-08-21
EP1472353A2 (de) 2004-11-03
CA2475821C (en) 2011-12-13
AU2003203097B2 (en) 2009-10-01
CA2475821A1 (en) 2003-08-21
JP2005535287A (ja) 2005-11-24
AU2003203097A1 (en) 2003-09-04
AU2003203097C1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
NO20063026L (no) Antistoffer
MA40801B2 (fr) Anticorps anti-cd3, anticorps anti-cd123 et anticorps bispécifiques se liant spécifiquement à cd3 et/ou cd123
MX338940B (es) Identificacion de epitopos ige novedosos.
DK1362109T3 (da) Rekombinante oligomere protein-komplekser med foröget immunogent potentiale
BG104149A (bg) Белтъци, свързващи интерлевкин-18, тяхното получаване и приложение
BRPI0506771A (pt) anticorpo, e, composição farmacêutica
MY153249A (en) Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
NO20071192L (no) Varianter av FC-regioner.
ATE543906T1 (de) Antigen von streptococcus aus der b-gruppe
ATE387629T1 (de) Gemeinsame epitope von antigenen aus einer multigen-familie
ATE356206T1 (de) Menschliches krebsantigen ny eso-1/cag-3 und dazu kodierendes gen
EP1412388A4 (de) Von dd 3b6/22 abgeleitete humanisierte antikörper mit spezifität für das d-dimer fragment von fibrin
GB0008305D0 (en) Treatment of fungal infections
ATE537186T1 (de) P53-bindendes polypeptid
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
ATE453714T1 (de) Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen
EA200702193A1 (ru) Гликозилирование белков
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
EA200601743A1 (ru) Выделенный полипептид реналазы и его применение
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
DE60235223D1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
ATE230761T1 (de) Monoklonale antikörper gegen einen komplex aus humanem act und einer serinprotease
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente